-
When the general public pictures genetic research, they think of new screening tests to detect rare diseases, or they think of cutting-edge gene therapy experiments that have the potential to completely reverse a previously fatal condition. However, the real promise of genetic knowledge, say many experts, is in the potential to target drug therapy for common diseases, such as heart disease and cancer, that affect huge numbers of people.
-
-
Hypothyroidism and Pregnancy; Anti-Depressants and the Risk of Suicide; FDA Actions; Brief Notes.
-
-
-
In patients with acute lung injury or ARDS, the addition of higher PEEP levels to the strategy of a low tidal volume does not improve clinical outcomes.
-
There currently exists much evidence to direct the application of Noninvasive Positive Pressure Ventilation (NPPV). NPPV for the treatment of patients with acute respiratory failure has generated several meta-analyses and systematic reviews,1-4 including a recent one by Dean R. Hess PhD, RRT.
-
While only two drug-eluting coronary stents are currently cleared for sale in the U.S., numerous others are peeking over the horizon, awaiting their turn in the sun. The existing products and those that are on the way reflect a variety of different approaches in terms of both the drugs and the polymer coatings chosen by the companies vying for a spot in the marketplace.
-
This year's small but highly regarded Summer in Seattle (SIS) conference, whose stated goal is to provide a state-of-the-art perspective on the field of interventional cardiology and vascular therapies, was held here in the latter part of July amidst glorious summertime weather.
-
Attendance at the 12th annual Medical Device Conference sponsored by Wilson Sonsini Goodrich & Rosati (Palo Alto, California), with events held here and up the road in Palo Alto, was up 6% from the previous year, totaling 465.